JP2019031521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019031521A5 JP2019031521A5 JP2018190468A JP2018190468A JP2019031521A5 JP 2019031521 A5 JP2019031521 A5 JP 2019031521A5 JP 2018190468 A JP2018190468 A JP 2018190468A JP 2018190468 A JP2018190468 A JP 2018190468A JP 2019031521 A5 JP2019031521 A5 JP 2019031521A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cap
- mrna
- composition according
- formulated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751504P | 2013-01-11 | 2013-01-11 | |
| US61/751,504 | 2013-01-11 | ||
| JP2016218023A JP6473729B2 (ja) | 2013-01-11 | 2016-11-08 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218023A Division JP6473729B2 (ja) | 2013-01-11 | 2016-11-08 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020186487A Division JP2021019644A (ja) | 2013-01-11 | 2020-11-09 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019031521A JP2019031521A (ja) | 2019-02-28 |
| JP2019031521A5 true JP2019031521A5 (enExample) | 2019-06-13 |
| JP6956059B2 JP6956059B2 (ja) | 2021-10-27 |
Family
ID=51167392
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552801A Pending JP2016511230A (ja) | 2013-01-11 | 2014-01-10 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
| JP2016218023A Active JP6473729B2 (ja) | 2013-01-11 | 2016-11-08 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
| JP2018190468A Active JP6956059B2 (ja) | 2013-01-11 | 2018-10-05 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
| JP2020186487A Withdrawn JP2021019644A (ja) | 2013-01-11 | 2020-11-09 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552801A Pending JP2016511230A (ja) | 2013-01-11 | 2014-01-10 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
| JP2016218023A Active JP6473729B2 (ja) | 2013-01-11 | 2016-11-08 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020186487A Withdrawn JP2021019644A (ja) | 2013-01-11 | 2020-11-09 | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20150344537A1 (enExample) |
| EP (2) | EP3501551B1 (enExample) |
| JP (4) | JP2016511230A (enExample) |
| KR (2) | KR102056511B1 (enExample) |
| CN (1) | CN105473163A (enExample) |
| AU (1) | AU2014205298B2 (enExample) |
| CA (2) | CA3152721A1 (enExample) |
| ES (1) | ES2738315T3 (enExample) |
| IL (2) | IL239898B (enExample) |
| NZ (1) | NZ710495A (enExample) |
| PL (1) | PL2943226T3 (enExample) |
| SG (2) | SG10201603946PA (enExample) |
| WO (1) | WO2014110366A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102056511B1 (ko) * | 2013-01-11 | 2019-12-16 | 마크 씨 허즈버그 | ｍＲＮＡ 트랜스펙션을 수반하는 치료 조성물 및 방법 |
| CA3040359A1 (en) | 2016-11-07 | 2018-05-11 | Westfalische Wilhelms-Universitat Munster | S100a8/s100a9-induced immunotolerance in newborn subjects |
| CN107841508A (zh) * | 2017-11-29 | 2018-03-27 | 重庆市中医院 | 含抑铁素重组减毒沙门杆菌及构建方法、表达或递送载体 |
| EP3553525A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Diagnostics of mild or advanced periodontitis |
| EP3553523A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Diagnostics of mild or advanced periodontitis |
| JP6891157B2 (ja) * | 2018-11-15 | 2021-06-18 | 正生 池本 | 機能性ペプチド、それを用いた大腸炎用医薬およびデリバリー剤 |
| CN114561381A (zh) * | 2022-03-14 | 2022-05-31 | 桂林医学院 | 免疫mRNA及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2797402B1 (fr) * | 1999-07-15 | 2004-03-12 | Biomerieux Stelhys | Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune |
| WO2001023002A1 (en) * | 1999-09-30 | 2001-04-05 | National Jewish Medical And Research Center | Method for inhibition of pathogenic microorganisms |
| US7754676B2 (en) * | 2000-09-15 | 2010-07-13 | The United States Of America As Represented By The Department Of Health And Human Services | Defensin-antigen fusion proteins |
| US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| DE10121254A1 (de) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind |
| WO2004089292A2 (en) * | 2003-04-04 | 2004-10-21 | The Regents Of The University Of California | Immunomodulatory agents for treatment of inflammatory diseases |
| DE10324997A1 (de) * | 2003-06-03 | 2004-12-23 | Switch Biotech Ag | Mrp8/Mrp14 Inhibitoren und ihre Verwendung zur Prävention und/oder Behandlung von hypertrophen Narben und Keloiden |
| WO2005084180A2 (en) | 2003-12-19 | 2005-09-15 | University Of Cincinnati | Polyamides and polyamide complexes for delivery of oligonucleotide decoys |
| WO2006085987A2 (en) * | 2004-07-09 | 2006-08-17 | University Of Iowa Research Foundation | Rna interference in respiratory epitheial cells |
| US20090305963A1 (en) * | 2005-01-19 | 2009-12-10 | Sukhatme Vikas P | Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis |
| KR100681763B1 (ko) * | 2005-02-28 | 2007-02-15 | 재단법인 목암생명공학연구소 | 인간 리포칼린 2를 유효성분으로 포함하는 암 전이 억제용약학적 조성물, 이를 이용한 암 전이 억제 방법 |
| US8501478B2 (en) | 2006-06-15 | 2013-08-06 | University Of Cincinnati | Trehalose click polymers for delivery of biologically active molecules |
| EP2167653A2 (en) * | 2007-06-11 | 2010-03-31 | University Of Vermont And State Agricultural College | Treatments involving glutaredoxins and similar agents |
| US8916163B1 (en) * | 2007-12-21 | 2014-12-23 | Vanderbilt University | Method for treating microbial infections |
| DE102010040153A1 (de) * | 2010-09-02 | 2012-03-08 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Stoffkombination zur Behandlung von entzündlichen oder infektiösen Erkrankungen |
| DE12722942T1 (de) * | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US10174081B2 (en) * | 2011-04-21 | 2019-01-08 | George Mason Research Foundation, Inc. | Antimicrobial peptides and uses therefore |
| KR102056511B1 (ko) * | 2013-01-11 | 2019-12-16 | 마크 씨 허즈버그 | ｍＲＮＡ 트랜스펙션을 수반하는 치료 조성물 및 방법 |
-
2014
- 2014-01-10 KR KR1020157021685A patent/KR102056511B1/ko active Active
- 2014-01-10 SG SG10201603946PA patent/SG10201603946PA/en unknown
- 2014-01-10 KR KR1020187006399A patent/KR102119985B1/ko active Active
- 2014-01-10 CA CA3152721A patent/CA3152721A1/en active Pending
- 2014-01-10 CN CN201480011234.4A patent/CN105473163A/zh active Pending
- 2014-01-10 ES ES14738078T patent/ES2738315T3/es active Active
- 2014-01-10 EP EP19155020.1A patent/EP3501551B1/en active Active
- 2014-01-10 PL PL14738078T patent/PL2943226T3/pl unknown
- 2014-01-10 WO PCT/US2014/011041 patent/WO2014110366A1/en not_active Ceased
- 2014-01-10 US US14/760,077 patent/US20150344537A1/en not_active Abandoned
- 2014-01-10 SG SG11201505431XA patent/SG11201505431XA/en unknown
- 2014-01-10 NZ NZ71049514A patent/NZ710495A/en unknown
- 2014-01-10 EP EP14738078.6A patent/EP2943226B1/en active Active
- 2014-01-10 JP JP2015552801A patent/JP2016511230A/ja active Pending
- 2014-01-10 CA CA2901409A patent/CA2901409C/en active Active
- 2014-01-10 AU AU2014205298A patent/AU2014205298B2/en active Active
-
2015
- 2015-07-12 IL IL239898A patent/IL239898B/en active IP Right Grant
-
2016
- 2016-11-08 JP JP2016218023A patent/JP6473729B2/ja active Active
-
2018
- 2018-10-05 JP JP2018190468A patent/JP6956059B2/ja active Active
- 2018-10-10 IL IL262252A patent/IL262252B/en not_active IP Right Cessation
-
2020
- 2020-04-07 US US16/842,489 patent/US11912744B2/en active Active
- 2020-11-09 JP JP2020186487A patent/JP2021019644A/ja not_active Withdrawn
-
2024
- 2024-01-30 US US18/427,711 patent/US12448421B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019031521A5 (enExample) | ||
| JP2010501596A5 (enExample) | ||
| JP2015511609A5 (enExample) | ||
| JP2007509984A5 (enExample) | ||
| ME02000B (me) | Peptidni inhibitori jnk signalnog transdukcijskog puta koji su permeabilni za ćeliju | |
| JP2020023567A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP6956059B2 (ja) | 治療用組成物およびｍＲＮＡトランスフェクションを含む方法 | |
| Kay | Mucoepidermoid carcinoma of the esophagus. Report of two cases | |
| JP2011517675A5 (enExample) | ||
| JP2014506231A5 (enExample) | ||
| Wettzel et al. | Carcinoma arising in a rectal duplication (enterocystoma) | |
| JP2008546811A5 (enExample) | ||
| ME02422B (me) | Farmaceutska kompozicija koja uključuje selenit ili uključuje jedinjenja selenita za tretman displazije ili karcinoma cerviksa | |
| Kazakov et al. | Cutaneous type adnexal tumors outside the skin | |
| JP2009507077A5 (enExample) | ||
| Jin et al. | Precision therapy for cancer prevention by targeting carcinogenesis | |
| Shin et al. | A case of nonpolypoid cancer arising from colonic muco-submucosal elongated polyp | |
| CN107693517B (zh) | 阿西替尼和px-478在治疗鼻咽癌方面的应用 | |
| CN103877084B (zh) | 一种治疗肛周溃疡的外用药物 | |
| CN114984233A (zh) | 一种基于鲵皮肤分泌物的局部给药系统及其应用 | |
| JP2007511492A5 (enExample) | ||
| Laskaris | Potentially Malignant Disorders | |
| Talmassons et al. | LA TRACHEOBRONCOSCOPIA IN ANESTESIA E RIANIMAZIONE | |
| JPWO2020103859A5 (enExample) |